Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease

por Folkerts, Kerstin, Millier, Aurelie, Smela, Beata, Olewinska, Elzbieta, Schmedt, Niklas, Mernagh, Paul, Kovesdy, Csaba P.
Publicado 2022

Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease

por Cowie, Martin R, Lamy, André, Levy, Pierre, Mealing, Stuart, Millier, Aurélie, Mernagh, Paul, Cristeau, Olivier, Bowrin, Kevin, Briere, Jean-Baptiste
Publicado 2020